0001209191-20-024484.txt : 20200415 0001209191-20-024484.hdr.sgml : 20200415 20200415164154 ACCESSION NUMBER: 0001209191-20-024484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200409 FILED AS OF DATE: 20200415 DATE AS OF CHANGE: 20200415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Basenese Lou CENTRAL INDEX KEY: 0001809482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37969 FILM NUMBER: 20794147 MAIL ADDRESS: STREET 1: 3600 GREEN COURT, SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDRA Life Sciences Inc. CENTRAL INDEX KEY: 0001681682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 260579295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 BUSINESS PHONE: 734-335-0468 MAIL ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 FORMER COMPANY: FORMER CONFORMED NAME: Endra Inc. DATE OF NAME CHANGE: 20160805 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-09 0 0001681682 ENDRA Life Sciences Inc. NDRA 0001809482 Basenese Lou 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105 1 0 0 0 Common Stock 2020-04-09 4 A 0 41587 0.00 A 41587 D Stock Option (right to buy) 0.70 2020-04-09 4 A 0 50000 0.00 A 2030-04-09 Common Stock 50000 50000 D Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Includes unvested restricted stock units. Represents a stock option award granted on April 9, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy. This stock option grant becomes exercisable in three equal annual installments beginning April 9, 2021. /s/ Louis J. Basenese by Mark Busch, attorney-in-fact 2020-04-15